Onconetix, Inc. Secures $2.5 Million in Funding Through Promissory Note
PUBLIC · ONCOSep 11, 2026
Amount Raised
$2.5 Million
Round Type
Debt Financing
CincinnatiBiotechnology
Investors
Realbotix, Llc
Description
On September 11, 2026, Onconetix, Inc. entered into a Grid Promissory Note with Realbotix, LLC, providing loans up to $5.0 million. An initial amount of $2.5 million was advanced on the same date. The funds are intended for Realbotix's general corporate and working capital purposes
Company Information
Company
Onconetix
Location
Cincinnati, Ohio, United States
About
Onconetix, Inc. is a commercial stage biotechnology company focused on developing and commercializing therapeutics, diagnostics, and services for clinicians and patients in oncology.
Fundz sees it the moment Onconetix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.